Clinical Trials Browser

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

NCT06477939 2024-06-27

THREE-GLEES

Phase 3 Not yet recruiting

554 enrolled

CNS

Hypoxia, Brain Neoplasms, Glioblastoma

NCT06041555 2024-02-20

ISRAR

Recruiting

600 enrolled

CNSGenitourinaryGynecologicHead & Neck

Hypoxia, Uterine Cervical Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms

NCT04338867 2020-04-22

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase 2 Completed

96 enrolled

CNSThoracic

Hypoxia, Brain Neoplasms, Lung Neoplasms

NCT02584400 2019-03-08

HX4 SD

Phase 2 Terminated

1 enrolled

CNSGastrointestinalGenitourinary

Hypoxia, Brain Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Rectal Neoplasms

NCT03716986 2018-10-23

GLIOXYMAGE

Phase NA Unknown

20 enrolled

CNS

Hypoxia, Glioma

NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Phase EARLY_PHASE1 Completed

10 enrolled

CNS

Hypoxia, Glioblastoma

NCT00906893 2013-02-28

MISOGLIO

Phase 2 Completed

14 enrolled

CNS

Hypoxia, Glioblastoma, Neoplasms

Clinical Trials

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome